239 related articles for article (PubMed ID: 27906679)
1. Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer.
Zhu Y; Si W; Sun Q; Qin B; Zhao W; Yang J
Oncotarget; 2017 Jan; 8(1):1023-1030. PubMed ID: 27906679
[TBL] [Abstract][Full Text] [Related]
2. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: An updated meta-analysis of 17079 individuals.
Guo W; Lu X; Liu Q; Zhang T; Li P; Qiao W; Deng M
Cancer Med; 2019 Aug; 8(9):4135-4148. PubMed ID: 31197958
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of platelet-to-lymphocyte ratio (PLR) in patients with breast cancer treated with neoadjuvant chemotherapy: a meta-analysis.
Qi X; Chen J; Wei S; Ni J; Song L; Jin C; Yang L; Zhang X
BMJ Open; 2023 Nov; 13(11):e074874. PubMed ID: 37996220
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis.
Tan D; Fu Y; Su Q; Wang H
Medicine (Baltimore); 2016 Jun; 95(24):e3837. PubMed ID: 27310960
[TBL] [Abstract][Full Text] [Related]
6. High Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Breast Cancer: A Meta-Analysis.
Zhang M; Huang XZ; Song YX; Gao P; Sun JX; Wang ZN
Biomed Res Int; 2017; 2017():9503025. PubMed ID: 29082257
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
Leng J; Wu F; Zhang L
Front Oncol; 2022; 12():734948. PubMed ID: 35651788
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
[No Abstract] [Full Text] [Related]
9. Prognostic role of platelet to lymphocyte ratio in prostate cancer: A meta-analysis.
Wang J; Zhou X; He Y; Chen X; Liu N; Ding Z; Li J
Medicine (Baltimore); 2018 Oct; 97(40):e12504. PubMed ID: 30290605
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in non-metastatic breast cancer patients from a Hispanic population.
Ramos-Esquivel A; Rodriguez-Porras L; Porras J
Breast Dis; 2017; 37(1):1-6. PubMed ID: 28035906
[TBL] [Abstract][Full Text] [Related]
11. Platelet-to-lymphocyte ratio associated with the clinicopathological features and prognostic value of breast cancer: A meta-analysis.
Gong Z; Xin R; Li L; Lv L; Wu X
Int J Biol Markers; 2022 Dec; 37(4):339-348. PubMed ID: 35971299
[TBL] [Abstract][Full Text] [Related]
12. The pretreatment platelet-to-lymphocyte ratio predicts clinical outcomes in patients with cervical cancer: A meta-analysis.
Ma JY; Ke LC; Liu Q
Medicine (Baltimore); 2018 Oct; 97(43):e12897. PubMed ID: 30412089
[TBL] [Abstract][Full Text] [Related]
13. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients.
Krenn-Pilko S; Langsenlehner U; Thurner EM; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
Br J Cancer; 2014 May; 110(10):2524-30. PubMed ID: 24675383
[TBL] [Abstract][Full Text] [Related]
14. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of preoperative neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in the prognosis of resected early-stage patients with non-small cell lung cancer: A meta-analysis.
Cao W; Yu H; Zhu S; Lei X; Li T; Ren F; Zhou N; Tang Q; Zu L; Xu S
Cancer Med; 2023 Mar; 12(6):7065-7076. PubMed ID: 36480232
[TBL] [Abstract][Full Text] [Related]
17. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
Zhang N; Jiang J; Tang S; Sun G
Int Immunopharmacol; 2020 Aug; 85():106677. PubMed ID: 32531712
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis.
Zhang X; Zhao W; Yu Y; Qi X; Song L; Zhang C; Li G; Yang L
World J Surg Oncol; 2020 Jul; 18(1):191. PubMed ID: 32731872
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
Miao Y; Yan Q; Li S; Li B; Feng Y
Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
